Newsroom

Newsroom

Role of epigenetic regulators in Single Base Substitution patterns in AML

Literature
Read More

STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape

Literature
Read More

NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst®-Lung Liquid Biopsy Test

Press Release
Read More

NeoGenomics To Virtually Participate In 17th Annual Craig-Hallum Institutional Investor Conference

Press Release
Read More

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

Literature
Read More

NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference

Press Release
Read More

NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients

Press Release
Read More

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients